We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
-25.13%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$97.5B
AUM Growth
-$45.1B
Cap. Flow
-$1.57B
Cap. Flow %
-1.61%
Top 10 Hldgs %
35.7%
Holding
526
New
28
Increased
112
Reduced
187
Closed
33

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$691M
2
MELI icon
Mercado Libre
MELI
+$341M
3
SPOT icon
Spotify
SPOT
+$335M
4
WIX icon
WIX.com
WIX
+$315M
5
RBLX icon
Roblox
RBLX
+$233M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$334M
2
CBRE icon
CBRE Group
CBRE
+$310M
3
AMZN icon
Amazon
AMZN
+$302M
4
NVDA icon
NVIDIA
NVDA
+$296M
5
TTD icon
Trade Desk
TTD
+$255M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.49%
2 Healthcare 25.5%
3 Technology 17.13%
4 Communication Services 10.66%
5 Financials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
351
Johnson & Johnson
JNJ
$625B
$18K ﹤0.01%
99
+10
+11% +$1.78K
KFRC icon
352
Kforce
KFRC
$1.06B
$18K ﹤0.01%
295
– –
NVEE
353
DELISTED
NV5 Global
NVEE
$18K ﹤0.01%
620
+68
+12% +$2.04K
CHD icon
354
Church & Dwight Co
CHD
$24.5B
$17K ﹤0.01%
179
– –
DG icon
355
Dollar General
DG
$27.9B
$17K ﹤0.01%
+69
New +$16.1K
EXPE icon
356
Expedia Group
EXPE
$37.3B
$17K ﹤0.01%
176
+11
+7% +$1.56K
OPK icon
357
Opko Health
OPK
$1.02B
$17K ﹤0.01%
6,635
– –
SNA icon
358
Snap-on
SNA
$21.5B
$17K ﹤0.01%
86
– –
VRNT
359
DELISTED
Verint Systems
VRNT
$17K ﹤0.01%
395
– –
AVY icon
360
Avery Dennison
AVY
$13.4B
$16K ﹤0.01%
100
– –
BPMC
361
DELISTED
Blueprint Medicines
BPMC
$16K ﹤0.01%
315
– –
HUBB icon
362
Hubbell
HUBB
$27.2B
$16K ﹤0.01%
87
– –
LYFT icon
363
Lyft
LYFT
$6.63B
$16K ﹤0.01%
1,228
-119,493
-99% -$2.79M
INFN
364
DELISTED
Infinera Corporation Common Stock
INFN
$16K ﹤0.01%
2,941
– –
AYX
365
DELISTED
Alteryx Inc
AYX
$16K ﹤0.01%
336
– –
CELH icon
366
Celsius Holdings
CELH
$7.03B
$15K ﹤0.01%
690
-90
-12% -$1.74K
ENTA icon
367
Enanta Pharmaceuticals
ENTA
$400M
$15K ﹤0.01%
318
– –
GT icon
368
Goodyear
GT
$1.85B
$15K ﹤0.01%
1,400
– –
LHX icon
369
L3Harris
LHX
$53.4B
$15K ﹤0.01%
61
– –
SRPT icon
370
Sarepta Therapeutics
SRPT
$1.77B
$15K ﹤0.01%
199
+22
+12% +$1.62K
VIAV icon
371
Viavi Solutions
VIAV
$9.66B
$15K ﹤0.01%
1,142
– –
XPEL icon
372
XPEL
XPEL
$1.38B
$15K ﹤0.01%
326
+31
+11% +$1.46K
AOS icon
373
A.O. Smith
AOS
$8.7B
$14K ﹤0.01%
+263
New +$15.8K
GNTX icon
374
Gentex
GNTX
$5.07B
$14K ﹤0.01%
516
– –
INSM icon
375
Insmed
INSM
$28.6B
$14K ﹤0.01%
707
– –
13 14
15
16 17

Similar funds

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Baillie Gifford & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Baillie Gifford & Co held 526 positions worth $97.5B, down 32% from $143B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Baillie Gifford & Co's Q2 2022 filing shows 28 new, 112 increased, 187 reduced and 33 closed positions. Its largest new stake was Hershey: 94,977 shares worth $20.4M. The largest sale was Tesla, an estimated $334M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q2 2022 buy was Hershey: 94,977 shares worth $20.4M.
  • Baillie Gifford & Co added most to Royalty Pharma in Q2 2022, an estimated $691M increase.
  • Baillie Gifford & Co's biggest Q2 2022 reduction was Tesla, cutting an estimated $334M.
  • Baillie Gifford & Co fully exited iShares Silver Trust in Q2 2022, selling an estimated $21.2M.
  • Baillie Gifford & Co's ten largest holdings make up 36% of its $97.5B portfolio in Q2 2022.
  • Baillie Gifford & Co opened 28 new positions and closed 33 in Q2 2022.
  • Baillie Gifford & Co's portfolio value fell 32% quarter-over-quarter to $97.5B.

Based on Baillie Gifford & Co's 13F filing for Q2 2022, filed 8 Aug 2022.